The global pharmacovigilance market is expected to grow at a compound annual growth rate of 10.53% over the forecast period to reach a market size of US$11.041 billion in 2030 from US$7.071 billion in 2025. Pharmac...
The global pharmacovigilance market is expected to grow at a compound annual growth rate of 10.53% over the forecast period to reach a market size of US$11.041 billion in 2030 from US$7.071 billion in 2025.
Pharmacovigilance is the process or science that is related to detecting, assessing, and understanding the adverse effects of vaccines or medicines. The process of pharmacovigilance helps in detecting any risk and monitoring the effects of the medicines. It also helps in reducing the adverse effects of newly developed medicines. The process of pharmacovigilance includes two major processes, which comprise active and passive surveillance. The process of active surveillance helps in the proactive monitoring of the patients, while the passive surveillance process features voluntary reporting.
With the increasing global demand for the pharmaceutical sector, the pharmacovigilance market is forecasted to witness significant growth during the forecasted timeline. The process of pharmacovigilance helps in efficiently and safely developing new and more effective drugs and vaccines. With the increasing global demand for new drug development, various global leaders in the pharmaceutical market are expected to increase research and development to boost the efficiencies of pharmacovigilance platforms.
Similarly, the integration of new-age technologies, like artificial intelligence into the pharmaceutical sector is also expected to boost the efficiency of the pharmacovigilance platforms. Various global leaders have introduced key solutions and platforms in the global pharmacovigilance market. For instance, CorEvitas, a global leader in pharmaceutical evidence solutions, which was acquired by Thermos Fischer, announced the launch of CorEvidence in December 2023, a pharmacovigilance platform, which is aimed at clinical research registries.
The global pharmacovigilance market, under the clinical trial phase segment, is categorized into Preclinical, Phase I, Phase II, Phase III, and Phase IV. In the clinical trial phase segment of the global pharmacovigilance market, the preclinical category is forecasted to grow at a significant rate. The preclinical studies help in reducing the adverse effects and improving the safety of pharmaceutical drugs and vaccines. The preclinical pharmacovigilance process helps in offering the drug developer an extensive and initial report related to the drug developments.The service provider segment of the global pharmacovigilance market is categorized into contract outsourcing and in-house. The outsourcing category, under the service provider segment of the global pharmacovigilance market, is expected to attain a greater market share during the forecasted timeline. In the pharmacovigilance market, the outsourcing service provider offers a wide range of applications, which includes offering efficient and seamless services.
By end-user, the global pharmacovigilance market is segmented into pharmaceuticals, biotechnology companies, medical device manufacturers, and others. In the end-user segment, the pharmaceutical category is estimated to attain a greater market share. The pharmacovigilance platform offers a critical role in the development of new and advanced pharmaceutical drugs in the pharmaceutical industry.
Based on geography, the European region is expected to witness significant growth in the global pharmacovigilance market. Europe is among the biggest producers and developers of the pharmaceutical sector across the globe. Various nations like Germany, France, Spain, and Switzerland are among the biggest producers and exporters of pharmaceutical drugs and vaccines across the globe. Similarly, multiple governments in the region have also introduced key policies and investment opportunities to propel the development of drugs in the region, and simultaneously integrate new-age technologies into the pharmaceutical industries.
As a part of the report, the major players operating in the global pharmacovigilance market that have been covered are Cognizant, Sciformix (Covance), IQVIA, APCER Life Sciences, Inc., Navitas Life Sciences, BioClinica, Accenture, ArisGlobal, Capgemini, and FMD K&L Inc.
View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/global-pharmacovigilance-market
The market analytics report segments the global pharmacovigilance market as follows:- By Clinical Trial Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV
- By Service Provider
- Contract Outsourcing
- In-house
- By End-User
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- North America
- E-Pharma Market Share
- Pharmaceutical Excipients Market Report
- Clinical Trial Management System (CTMS) Market Report
Have questions?
More Press Releases
How Reliance's Bombay Creamery Launch Will Shake Up the Global Ice Cream Market, Expected to Reach USD 98.3 Billion by 2031
Reliance Consumer Products Limited (RCPL) has launched Bombay Creamery, an accessible-premium dairy ice cream brand made with real dairy cream and priced from as low as Rs 10, marking its dedicated entry into India's ice cream category. The launch, supported by the nationwide network of Reliance and a brisk marketing move, puts RCPL in the competition of some established brand names like Amul, Kwality Wall's, Mother Dairy, Vadilal and global brands like Magnum, Baskin-Robbins etc. The shift is a reflection of the premiumisation and innovation trends outlined in a new report by Knowledge Sourcing Intelligence, according to which the global ice cream market is worth USD 74.9 billion by 2026, and USD 98.3 billion by 2031.
How Abbott’s Libre Duo Launch Could Impact the Continuous Glucose Monitoring (CGM) Market, Expected to Reach USD 19.4 Billion by 2031
Abbott’s Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System represents a significant development in the continuous glucose monitoring (CGM) market by combining glucose and ketone monitoring within a single wearable device. In August 2026, the U.S. Food and Drug Administration (FDA) authorized Libre Duo for people aged 2 years and older living with diabetes, making it the first wearable device in the U.S. to continuously monitor ketone levels and the first globally to continuously monitor both glucose and ketones in one device. The system measures glucose and ketones every minute for up to 10 days and can transmit readings wirelessly to a compatible smartphone.
Voith and Jungheinrich’s Recent Automation and Electrification Developments Will Affect the Material Handling Market, Estimated to Reach USD 328.6 Billion by 2031
Material handling is advancing through electrification, automation, and digitally enabled operations. Voith’s PowerDrive Mining, Jungheinrich’s ETV 4i reach truck, and Reitar Logtech’s cooperation with Cainiao highlight developments in conveyor systems, warehouse productivity, and logistics infrastructure, supporting higher throughput, operational efficiency, integrated controls, and technology-driven material movement across industries.